These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 32359427)
21. Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson's disease. Zhang YN; Fan JK; Gu L; Yang HM; Zhan SQ; Zhang H J Neuroinflammation; 2021 Jan; 18(1):23. PubMed ID: 33461598 [TBL] [Abstract][Full Text] [Related]
22. High frequency electrical stimulation reduces α-synuclein levels and α-synuclein-mediated autophagy dysfunction. George J; Shafiq K; Kapadia M; Kalia LV; Kalia SK Sci Rep; 2024 Jul; 14(1):16091. PubMed ID: 38997273 [TBL] [Abstract][Full Text] [Related]
23. Cysteine cathepsins are essential in lysosomal degradation of α-synuclein. McGlinchey RP; Lee JC Proc Natl Acad Sci U S A; 2015 Jul; 112(30):9322-7. PubMed ID: 26170293 [TBL] [Abstract][Full Text] [Related]
24. Novel covalent modifications of alpha-synuclein during the recovery from proteasomal dysfunction. Kim YS; Lee SJ Biochem Biophys Res Commun; 2006 Aug; 346(4):1312-9. PubMed ID: 16806074 [TBL] [Abstract][Full Text] [Related]
25. Enhancing the Astrocytic Clearance of Extracellular α-Synuclein Aggregates by Ginkgolides Attenuates Neural Cell Injury. Hua J; Yin N; Xu S; Chen Q; Tao T; Zhang J; Ding J; Fan Y; Hu G Cell Mol Neurobiol; 2019 Oct; 39(7):1017-1028. PubMed ID: 31165943 [TBL] [Abstract][Full Text] [Related]
27. Alpha-synuclein's degradation in vivo: opening a new (cranial) window on the roles of degradation pathways in Parkinson disease. Ebrahimi-Fakhari D; McLean PJ; Unni VK Autophagy; 2012 Feb; 8(2):281-3. PubMed ID: 22301995 [TBL] [Abstract][Full Text] [Related]
28. The Interplay between Alpha-Synuclein Clearance and Spreading. Lopes da Fonseca T; Villar-Piqué A; Outeiro TF Biomolecules; 2015 Apr; 5(2):435-71. PubMed ID: 25874605 [TBL] [Abstract][Full Text] [Related]
29. α-Synuclein amino terminus regulates mitochondrial membrane permeability. Shen J; Du T; Wang X; Duan C; Gao G; Zhang J; Lu L; Yang H Brain Res; 2014 Dec; 1591():14-26. PubMed ID: 25446002 [TBL] [Abstract][Full Text] [Related]
30. The Parkinson disease-associated A30P mutation stabilizes alpha-synuclein against proteasomal degradation triggered by heme oxygenase-1 over-expression in human neuroblastoma cells. Song W; Patel A; Qureshi HY; Han D; Schipper HM; Paudel HK J Neurochem; 2009 Jul; 110(2):719-33. PubMed ID: 19457084 [TBL] [Abstract][Full Text] [Related]
31. Age-dependent accumulation of oligomeric SNCA/α-synuclein from impaired degradation in mutant LRRK2 knockin mouse model of Parkinson disease: role for therapeutic activation of chaperone-mediated autophagy (CMA). Ho PW; Leung CT; Liu H; Pang SY; Lam CS; Xian J; Li L; Kung MH; Ramsden DB; Ho SL Autophagy; 2020 Feb; 16(2):347-370. PubMed ID: 30983487 [TBL] [Abstract][Full Text] [Related]
32. Aggregate clearance of α-synuclein in Saccharomyces cerevisiae depends more on autophagosome and vacuole function than on the proteasome. Petroi D; Popova B; Taheri-Talesh N; Irniger S; Shahpasandzadeh H; Zweckstetter M; Outeiro TF; Braus GH J Biol Chem; 2012 Aug; 287(33):27567-79. PubMed ID: 22722939 [TBL] [Abstract][Full Text] [Related]
33. Crosstalk between the proteasome system and autophagy in the clearance of α-synuclein. Yang F; Yang YP; Mao CJ; Liu L; Zheng HF; Hu LF; Liu CF Acta Pharmacol Sin; 2013 May; 34(5):674-80. PubMed ID: 23603979 [TBL] [Abstract][Full Text] [Related]